See original article:
The Promise of Cell-Based Therapies for Diabetic Complications: Challenges and Solutions: Correction
In the article that appears on page 854 of the March 19, 2010, issue, the legend for Figure 2 should not contain a permission to reprint material from The American Diabetes Association. The legend for Figure 4 should contain a permission to reprint material from The American Diabetes Association. The legend for Figure 4 should read as follows:
Human CD34+ cells of nondiabetic, but not diabetic, origin integrate into degenerate vasculature in mouse eyes damaged by ischemia/reperfusion injury (Caballero et al25). Two days after intravitreal or systemic administration, integration of diabetic cells into existing vasculature was not observed (A), whereas cells of nondiabetic origin show extensive integration into small and medium sized vessels (yellow in the composite images) (B). Insets show separate red and green channels used to make the composite images. C, CD34+ cells home to an area of injury and traverse toward the ischemic region of the capillary (arrows). Copyright 2007 American Diabetes Association. From Diabetes 2007;56:960–967. Reprinted with permission from The American Diabetes Association.
Reference 49 is incorrect and should appear as follows:
49. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204–1219.
The authors and publisher regret these errors. These errors have been noted in the online version of the article, which is available at http://circres.ahajournals.org/cgi/content/full/106/5/854.
1. Jarajapu YPR, Grant MB. The Promise of Cell-Based Therapies for Diabetic Complications: Challenges and Solutions. Circ Res. 2010;106:854–869.